ATE322244T1 - Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen - Google Patents

Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen

Info

Publication number
ATE322244T1
ATE322244T1 AT00403596T AT00403596T ATE322244T1 AT E322244 T1 ATE322244 T1 AT E322244T1 AT 00403596 T AT00403596 T AT 00403596T AT 00403596 T AT00403596 T AT 00403596T AT E322244 T1 ATE322244 T1 AT E322244T1
Authority
AT
Austria
Prior art keywords
treatment
polyamino acid
acid derivatives
seborrhea
seborrhoea
Prior art date
Application number
AT00403596T
Other languages
English (en)
Inventor
Michel Philippe
Sylvie Cupferman
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE322244T1 publication Critical patent/ATE322244T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00403596T 2000-01-28 2000-12-19 Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen ATE322244T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0001210A FR2804321B1 (fr) 2000-01-28 2000-01-28 Utilisation de derives de polyaminoacides pour traiter la seborrhee et les desordres cutanes associes

Publications (1)

Publication Number Publication Date
ATE322244T1 true ATE322244T1 (de) 2006-04-15

Family

ID=8846504

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00403596T ATE322244T1 (de) 2000-01-28 2000-12-19 Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen

Country Status (7)

Country Link
US (1) US20020164360A9 (de)
EP (1) EP1123692B1 (de)
JP (1) JP2001253832A (de)
AT (1) ATE322244T1 (de)
DE (1) DE60027127T2 (de)
ES (1) ES2261173T3 (de)
FR (1) FR2804321B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2776510B1 (fr) * 1998-03-31 2002-11-29 Oreal Derives de polyamino-acides et leur utilisation dans des compositions de traitement des fibres keratiniques
FR2821550B1 (fr) * 2001-03-05 2004-04-23 Oreal Composition antirides comprenant un derive de polyaminoacides, et utilisation de ce compose pour lutter contre les rides de la peau
US20060147484A1 (en) * 2005-01-03 2006-07-06 Hestand Mark A Urushiol-induced contact dermatitis composition, method of use, and method of manufacture
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
FR2980691B1 (fr) * 2011-09-30 2014-03-14 Galderma Sa Composition de lavage
RS58019B1 (sr) 2012-11-13 2019-02-28 Galderma Sa Kompozicija gela za pranje sa bpo
SG11201503730PA (en) 2012-11-13 2015-06-29 Galderma Sa Bpo wash emulsion composition
WO2018089337A1 (en) * 2016-11-08 2018-05-17 The Regents Of The University Of California Compositions and methods for treating skin diseases and maintaining healthy skin
AU2022315277A1 (en) 2021-07-19 2024-01-18 Immunome, Inc. Immunoconjugates and methods
US11806405B1 (en) 2021-07-19 2023-11-07 Zeno Management, Inc. Immunoconjugates and methods
US11718754B2 (en) 2021-11-11 2023-08-08 Calusa Bio, Llc Poly(sarcosine) polymer excipients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147782A (en) * 1976-06-24 1979-04-03 William H. Rorer, Inc. Pharmaceutical detergent composition
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
US5681586A (en) * 1989-03-23 1997-10-28 Gordon; Arthur L. Enzyme-modified soy and soy/casein combination healing compositions
US5124313A (en) * 1989-06-02 1992-06-23 Schaeffer Hans A Methods of improved skin care and the treatment of dermatological conditions
DE4103275C1 (en) * 1991-02-04 1992-04-02 Dieter 2000 Hamburg De Bliesener Agent to prevent hair loss due to seborrhoea - contains peptide(s) from mare's milk, acetate, alpha-tocopherol-acetate of retinol
FR2718028B1 (fr) * 1994-04-01 1996-04-26 Sederma Sa Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des hydrolysats peptidiques modifiés.
DE19600480A1 (de) * 1996-01-09 1997-07-10 Beiersdorf Ag Verwendung von Serin-Proteinasen gegen Akne und entzündete Comedonen
ATE281150T1 (de) * 1996-09-13 2004-11-15 Univ Clemson Mittel zur akne behandlung
JPH10245396A (ja) * 1997-03-05 1998-09-14 Pola Chem Ind Inc オリゴペプタイドアルキルアミド誘導体を含有する組成物
DE19732139C2 (de) * 1997-07-25 2002-10-10 Max Planck Gesellschaft Mesomorphe Komplexe aus Vitamin A-Säure und kationischen Polyelektrolyten, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
FR2776510B1 (fr) * 1998-03-31 2002-11-29 Oreal Derives de polyamino-acides et leur utilisation dans des compositions de traitement des fibres keratiniques

Also Published As

Publication number Publication date
DE60027127T2 (de) 2006-11-09
US20010043935A1 (en) 2001-11-22
US20020164360A9 (en) 2002-11-07
FR2804321B1 (fr) 2003-08-15
FR2804321A1 (fr) 2001-08-03
EP1123692A2 (de) 2001-08-16
EP1123692A3 (de) 2001-08-29
EP1123692B1 (de) 2006-04-05
JP2001253832A (ja) 2001-09-18
DE60027127D1 (de) 2006-05-18
ES2261173T3 (es) 2006-11-16

Similar Documents

Publication Publication Date Title
ATE354565T1 (de) Hydroxyethylamin-derivate für die behandlung von alzheimer
EA200602191A1 (ru) 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
DE60225556D1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
NO992400L (no) Nye substituerte pyrazolderivater
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
ATE515253T1 (de) Zusammensetzungen auf basis von etyllinoleat und triethylcitrat zur behandlung von seborrhöe und akne
DE60226729D1 (de) Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
ATE234089T1 (de) Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen
ATE322244T1 (de) Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
ATE414090T1 (de) Tricyclische indolhydroxyethylaminderivate und deren verwendung bei der behandlung von alzheimer-krankheit
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
NO20010940D0 (no) TAN-1057 derivater
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
ATE421961T1 (de) Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält
ATE241640T1 (de) Fusidinsäure-derivate
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
CY1107483T1 (el) Παραγωγα πυριδαζινης, η χρηση τους ως φαρμακευτικα σκευασματα και η διαδικασια παρασκευης τους
HRP20060456A2 (hr) Inhibitori 11-beta-hidroksisteroid-dehidrogenaze tipa 1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties